Tyvaso Dpi Kit
Product Images NDC 66302-670

Product Visual Gallery

This gallery contains 65 technical images submitted to the FDA as part of the official labeling for Tyvaso Dpi (NDC 66302-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United Therapeutics Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tyvasodpi 01)

Chemical structure diagram of the active ingredient in Tyvaso DPI, showing a complex molecule with hydroxyl, methoxycarbonyl, and alkyl side chain groups.*

FDA Label Image

Figure 1 (Tyvasodpi 02)

A Kaplan-Meier curve comparing the percentage of patients with a greater 6-minute walk distance (6MWD) change over baseline between Tyvaso and placebo groups. The x-axis shows 6MWD change from baseline in meters, and the y-axis shows the percentage of patients with a greater change. Two lines represent Tyvaso (N=115) and placebo (N=120). The graph highlights 52% for Tyvaso and 32% for placebo at a 6MWD change around 20 meters.*

FDA Label Image

Figure 2 (Tyvasodpi 03)

A horizontal forest plot illustrating the placebo-corrected median treatment effect in meters for Tyvaso DPI across various subgroups, including age quartiles, gender, geographic region, etiology, baseline 6-minute walk distance quartiles, and background therapy. The left side lists sample sizes for placebo and Tyvaso groups, with effect sizes and confidence intervals plotted on the right axis.*

FDA Label Image

Figure 3 (Tyvasodpi 04)

A forest plot chart showing placebo-corrected median treatment effects over various study visits for Tyvaso DPI. The graph includes Week 4, Week 8, Week 12, Week 16, and Week 15 Trough, with corresponding 95% confidence intervals and H-L estimates. X-axis represents the treatment effect in meters.*

FDA Label Image

Figure 4 (Tyvasodpi 05)

A forest plot chart comparing the efficacy of Tyvaso DPI versus placebo across various patient subgroups. The plot displays hazard ratio estimates with 95% confidence intervals and p-values for subgroups including age, sex, baseline 6-minute walk distance, PH-ILD etiology, baseline PVR category, and maximum study drug dose in breaths. The horizontal axis shows the comparative benefit indicating whether Tyvaso or placebo is favored.*

FDA Label Image

Figure 5 (Tyvasodpi 06)

A Kaplan-Meier survival curve graph showing the percentage of patients without an event over a 16-week period comparing Tyvaso DPI and placebo groups. The graph includes lines for Tyvaso and placebo, with patient numbers at risk displayed below the x-axis labeled in weeks. Statistical results with p-values and hazard ratio are also shown on the plot.*

FDA Label Image

Figure A (Tyvasodpi 07)

An instructional diagram of the Tyvaso DPI inhaler showing its components. The image labels the top and bottom of the inhaler, removable blue mouthpiece cover, white mouthpiece, cartridge, cartridge cup, and blue base, illustrating how the parts fit together for assembly or use.*

FDA Label Image

Figure B (Tyvasodpi 08)

An illustration of a zippered carrying case, rectangular in shape with rounded edges, typically used for storing and protecting a portable medical device or inhaler like Tyvaso DPI.*

FDA Label Image

Figure C (Tyvasodpi 09)

Blister card packaging for Tyvaso DPI showing seven strips per blister card, with each strip containing four cartridges. The label displays the proprietary name Tyvaso DPI, available strengths (16, 32, 48, 64, and 80 micrograms per cartridge), and the labeler United Therapeutics Corporation.*

FDA Label Image

Figure D (Tyvasodpi 10)

Illustration of Tyvaso DPI inhaler devices in four different strengths: 16 mcg, 32 mcg, 48 mcg, and 64 mcg. Each strength is shown from top and side views with distinct colors for each dose, representing the inhaler design variations. No 80 mcg device is shown.*

FDA Label Image

Figure E (Tyvasodpi 11)

An instructional diagram illustrating the storage of a product inside a cabinet. The image shows a cabinet door open with shelves inside and an arrow indicating placement or retrieval of a blue and white device from the top shelf.*

FDA Label Image

Figure F (Tyvasodpi 12)

An instructional illustration showing three arrows pointing from a packaged blister strip to a suitcase, a cabinet box, and a hard plastic case, indicating storage or carrying options for Tyvaso DPI inhalation capsules.*

FDA Label Image

Figure H (Tyvasodpi 13)

An instructional diagram illustrating placing a device on a shelf inside a cabinet. The diagram shows a hand holding a labeled device above an open cabinet, with an arrow indicating the device is being set down on a shelf inside the cabinet.*

FDA Label Image

Image (Tyvasodpi 14)

Tyvaso DPI inhaler device shown in black color with a compact rectangular shape. The device features a mouthpiece on one end and a sliding mechanism on the top, used for delivering the specified doses of 16 ug to 80 ug. Labeler information is not visible on the device. No additional text or packaging is present in the image.*

FDA Label Image

Image (Tyvasodpi 15)

An illustration of an analog clock showing the time as 2:55. The clock face includes hour, minute, and second markers with black numbers on a white background.*

FDA Label Image

Figure G (Tyvasodpi 16)

An instructional diagram depicting a closed refrigerator with an open compartment inside, highlighting the storage of medication or product within the refrigerator. An orange arrow points from a blister pack of capsules or tablets toward the interior of the refrigerator compartment.*

FDA Label Image

Image (Tyvasodpi 17)

Packaging label image of a single purple cartridge for Tyvaso DPI by United Therapeutics Corporation. The cartridge design is shown clearly without any dosage strength or additional text visible on the label area.*

FDA Label Image

Image (Tyvasodpi 18)

Tyvaso DPI inhaler device in dark blue color, designed for delivering inhaled medication. The image shows the inhaler from an angled perspective, highlighting its compact, handheld shape and cartridge insertion area. No textual information visible on the device itself.*

FDA Label Image

Image (Tyvasodpi 19)

An illustration of a light blue cartridge labeled as a component for Tyvaso DPI inhaler, used in delivering specified doses of the medication in micrograms. The cartridge is shaped to fit into the inhaler device, showing connection and flow features.*

FDA Label Image

Image (Tyvasodpi 20)

Packaging label image showing a light green cartridge for Tyvaso DPI inhalation powder. The cartridge is a single-dose unit likely corresponding to one of the Tyvaso DPI strengths ranging from 16 mcg to 80 mcg per cartridge, manufactured by United Therapeutics Corporation.*

FDA Label Image

Figure J (Tyvasodpi 21)

An instructional diagram showing the configuration of blister packs containing Tyvaso DPI capsules in various strengths (16 ug/1 to 80 ug/1). The image illustrates how multiple blister strips containing circular capsules are arranged and indicates usage with an arrow pointing to a labeled medication container for Tyvaso DPI by United Therapeutics Corporation.*

FDA Label Image

Figure K (Tyvasodpi 22)

Packaging label of Tyvaso DPI inhalation powder showing multiple strengths: 16 ug, 32 ug, 48 ug, 64 ug, and 80 ug per inhalation unit. The label includes the proprietary name Tyvaso DPI and indicates the labeler United Therapeutics Corporation. An expiration date is marked as MM/YYYY.*

FDA Label Image

Figure I (Tyvasodpi 23)

An illustration showing two cartridge types used in Tyvaso DPI inhalers: a dark blue cartridge labeled as 32 mcg and a light blue cartridge labeled as 48 mcg. The image visually differentiates the cartridges by color and shape.*

FDA Label Image

Figure L (Tyvasodpi 24)

An instructional illustration showing hands removing a small cartridge from a blister pack for Tyvaso DPI. The right side shows a detailed close-up of the cartridge being held between fingers, with a green checkmark indicating correct handling.*

FDA Label Image

Image (Tyvasodpi 25)

FDA Label Image

Image (Tyvasodpi 26)

FDA Label Image

Image (Tyvasodpi 27)

An illustration of a Tyvaso DPI inhalation device, showing the mouthpiece and trigger mechanism designed for delivering dry powder medication.*

FDA Label Image

Image (Tyvasodpi 28)

An illustration of a clock face showing the time at approximately 1:45. The clock is round with black numbers and tick marks on a white background, indicating standard time.*

FDA Label Image

Figure M (Tyvasodpi 29)

An instructional illustration showing a Tyvaso DPI unit dose blister packaging. The image depicts the blister strip containing individual doses for inhalation, designed to be used with the Tyvaso DPI inhaler device by United Therapeutics Corporation.*

FDA Label Image

Figure N (Tyvasodpi 30)

An instructional illustration showing a hand holding and opening a Tyvaso DPI inhaler by lifting the blue cap upward. A clock symbol indicates a 10-minute timing, suggesting a preparation or waiting step related to use.*

FDA Label Image

Figure O (Tyvasodpi 31)

An instructional illustration depicting a hand inserting a component into a Tyvaso DPI device. The image shows the placement of a cartridge or dose into the inhaler mouthpiece area, indicated by an orange downward arrow guiding the part into position.*

FDA Label Image

Figure P (Tyvasodpi 32)

An instructional diagram showing the assembly of a component of the Tyvaso DPI inhaler device. The image demonstrates aligning the pointed end of a small cartridge with the inhaler mechanism, indicated by arrows and a zoomed view to ensure correct positioning.*

FDA Label Image

Figure Q (Tyvasodpi 33)

An instructional illustration showing a hand positioning the mouthpiece cover of a Tyvaso DPI (dry powder inhaler) device. The thumb is lifting the cover upwards and away from the base, indicating the step to open the inhaler prior to use.*

FDA Label Image

Figure R (Tyvasodpi 34)

An instructional illustration related to Tyvaso DPI inhaler use, showing a device with a level indicator. The diagram includes a visual cue labeled 'KEEP INHALER LEVEL' to guide proper handling orientation during use.*

FDA Label Image

Image (Tyvasodpi 35)

An instructional illustration showing a hand holding the Tyvaso DPI inhaler with a red circle and diagonal line crossing it, indicating an action is prohibited. The image suggests not to shake or drop the inhaler, as particles are shown falling from it.*

FDA Label Image

Image (Tyvasodpi 36)

An instructional illustration showing a hand holding a dry powder inhaler (DPI) with loose powder spilling out, overlaid by a red circle and slash symbol indicating not to shake the inhaler or allow powder to spill.*

FDA Label Image

Image (Tyvasodpi 37)

An instructional illustration showing a figure holding a blue device vertically with an arrow pointing upwards, indicating the direction of use. The image is overlaid with a red circle and a diagonal line, indicating an action that is not allowed or should be avoided when using the device.*

FDA Label Image

Figure T (Tyvasodpi 38)

An instructional illustration showing the preparation for inhalation of Tyvaso DPI. A hand holds a blister strip with a capsule, while the other hand holds an inhaler device. An orange arrow indicates placing the capsule into the inhaler for use.*

FDA Label Image

Figure U (Tyvasodpi 39)

An instructional illustration showing how to hold the Tyvaso DPI inhaler device level during use. The sequence shows a hand holding the inhaler horizontally at mouth level, demonstrating proper positioning for inhalation with the user's profile visible on the right side. A bubble level on the inhaler indicates correct horizontal alignment.*

FDA Label Image

Figure V (Tyvasodpi 40)

An instructional illustration showing a hand holding the Tyvaso DPI inhaler and a person exhaling or inhaling from it. The diagram features directional arrows demonstrating the airflow or breath interaction with the inhaler device.*

FDA Label Image

Figure W (Tyvasodpi 41)

Instructional illustration showing how to use the Tyvaso DPI inhaler. It depicts a person holding the inhaler to their mouth with an arrow indicating the direction of inhalation to release the dose.*

FDA Label Image

Figure X (Tyvasodpi 42)

An instructional illustration showing a person holding a Tyvaso DPI inhaler near their mouth, exhaling smoke or vapor. An orange arrow beside the image indicates a downward motion of the device or hand.*

FDA Label Image

Figure Y (Tyvasodpi 43)

An instructional illustration showing a person holding a Tyvaso DPI inhaler near their mouth, demonstrating the proper positioning for inhalation.*

FDA Label Image

Figure Z (Tyvasodpi 44)

An instructional illustration showing how to use the Tyvaso DPI inhaler. It depicts a person holding the inhaler near their mouth and inhaling, with arrows indicating the direction of airflow during inhalation.*

FDA Label Image

Figure Aa (Tyvasodpi 45)

An instructional illustration showing two hands interacting with a blue and white device, likely demonstrating how to assemble or use the Tyvaso DPI inhaler device by United Therapeutics Corporation.*

FDA Label Image

Figure Ab (Tyvasodpi 46)

An instructional illustration showing a hand opening the cap of a Tyvaso DPI inhaler device. The image demonstrates how to lift the top cover in preparation for use, with an orange arrow indicating the direction to open the inhaler, which is branded by United Therapeutics Corporation.*

FDA Label Image

Figure Ac (Tyvasodpi 47)

An instructional illustration showing a hand placing a small cartridge into the base of a Tyvaso DPI inhaler device. An orange arrow indicates the upward direction in which the cartridge should be inserted into the open inhaler base on a flat surface.*

FDA Label Image

Figure Ad (Tyvasodpi 48)

An instructional illustration showing the correct handling of a Tyvaso DPI inhaler. It depicts a new device with a green checkmark for correct positioning or use, and a used device with a red prohibition symbol and an arrow indicating an incorrect action or positioning.*

FDA Label Image

Figure Ae (Tyvasodpi 49)

Instructional illustration showing a hand holding a small inhaler device being disposed of into a trash bin labeled 'TRASH'. The image likely represents proper disposal of the Tyvaso DPI inhaler device after use.*

FDA Label Image

Figure Af (Tyvasodpi 50)

An illustration showing two cartridge types for Tyvaso DPI: a dark blue cartridge labeled 32 mcg and a light blue cartridge labeled 48 mcg, positioned to indicate they can be combined or used together.*

FDA Label Image

Figure Ag (Tyvasodpi 51)

This instructional diagram for Tyvaso DPI shows the correct and incorrect ways to position the inhaler device. The top row marked with a green check indicates the proper new device orientation, while the bottom row with a red prohibition sign and arrow illustrates the incorrect orientation for a used device, demonstrating the opening or handling method.*

FDA Label Image

Figure Ai (Tyvasodpi 52)

An instructional illustration showing a hand discarding a small blue and white device part into a trash bin labeled 'TRASH'. The image likely relates to proper disposal steps for a component of the Tyvaso DPI inhaler device by United Therapeutics Corporation.*

FDA Label Image

Figure Ah (Tyvasodpi 53)

Illustration of a calendar page with dates marked from 1 to 7, highlighting the 8th with a red circle and the instruction 'REPLACE AFTER 7 DAYS' in red text below, likely indicating a 7-day usage or replacement schedule.*

FDA Label Image

Principal Display Panel (16 mcg Maintenance Kit)

Packaging label for Tyvaso DPI (treprostinil) inhalation powder Maintenance Kit 16 mcg per cartridge. The box contains 112 cartridges plus 5 inhalers and is labeled for oral inhalation only. The label shows the brand name, strength, and a blue and gray graphic design on a white background, with United Therapeutics Corporation as the labeler. The box is primarily purple with white text.*

FDA Label Image

Principal Display Panel (16 mcg Institutional Kit)

Packaging label for Tyvaso DPI 16 mcg per cartridge Institutional Kit by United Therapeutics Corporation. The label shows branding with the proprietary name, active ingredient treprostinil, dosage strength, and inhalation powder form. The kit contains 16 cartridges, each with 16 mcg per cartridge, plus 2 inhalers. Storage instructions and manufacturer information are also visible.*

FDA Label Image

Principal Display Panel (32 mcg Maintenance Kit)

Packaging label for Tyvaso DPI Maintenance Kit containing 32 mcg per cartridge of treprostinil inhalation powder. The label includes product branding, a depiction of the inhaler device, and kit contents: 112 cartridges with 32 mcg per cartridge plus 5 inhalers. The labeler is United Therapeutics Corporation.*

FDA Label Image

Principal Display Panel (32 mcg Institutional Kit)

Packaging label for Tyvaso DPI 32 mcg per cartridge Institutional Kit by United Therapeutics Corporation. The label shows the product name, strength, and dosage form as inhalation powder, along with a depiction of the inhaler device and cartridge. The kit contains 16 cartridges each with 32 mcg of treprostinil and 2 inhalers. Storage instructions and barcodes are also visible on the packaging.*

FDA Label Image

Principal Display Panel (48 mcg Maintenance Kit)

Packaging label for Tyvaso DPI 48 mcg inhalation powder Maintenance Kit by United Therapeutics Corporation. The kit contains 12 cartridges, each with 48 mcg per cartridge, and 5 inhalers for oral inhalation only. The label features the product name, strength, a graphic of the inhaler device, and storage instructions.*

FDA Label Image

Principal Display Panel (48 mcg Institutional Kit)

Tyvaso DPI 48 mcg per cartridge Institutional Kit packaging label showing the product name with active ingredient treprostinil, inhalation powder. The kit contains 16 cartridges each with 48 mcg per cartridge and 2 inhalers. Labeler is United Therapeutics Corporation. The label includes storage instructions and usage details, along with barcodes and website www.tyvasodpi.com.*

FDA Label Image

Principal Display Panel (64 mcg Maintenance Kit)

Packaging label for Tyvaso DPI Maintenance Kit containing 64 mcg per cartridge of treprostinil inhalation powder. The label shows the kit includes 112 cartridges, each with 64 mcg, plus 5 inhalers. The manufacturer is United Therapeutics Corporation. The label features product name, strength, dosage form, usage instructions, and storage information on a primarily white and green background.*

FDA Label Image

Principal Display Panel (64 mcg Institutional Kit)

Packaging label for Tyvaso DPI 64 mcg per cartridge Institutional Kit by United Therapeutics Corporation. The label shows the inhalation powder form with 16 cartridges each containing 64 mcg per cartridge, plus 2 inhalers. Instructions include storage conditions and usage information. The kit is for oral inhalation only and not for initial titration.*

FDA Label Image

Principal Display Panel (16 mcg 32 mcg Titration Kit)

Packaging label for Tyvaso DPI (treprostinil) inhalation powder Titration Kit containing 16 mcg and 32 mcg per cartridge strengths. Label shows kit contents including cartridges and inhalers, and features United Therapeutics Corporation as the labeler. Design includes product branding, website, and usage instructions on a predominantly white and blue background.*

FDA Label Image

Principal Display Panel (32 mcg 48 mcg Maintenance Kit)

Packaging label for Tyvaso DPI (treprostinil) inhalation powder Maintenance Kit by United Therapeutics Corporation. The label highlights cartridge strengths of 32 mcg and 48 mcg per cartridge. The kit contains multiple cartridges and inhalers, designed for oral inhalation. The label features the product name, strengths, usage designation, and a product image of the inhaler device.*

FDA Label Image

Principal Display Panel (32 mcg 48 mcg Institutional Kit)

Tyvaso DPI Institutional Kit packaging label featuring treprostinil inhalation powder. The kit contains 16 cartridges of 32 mcg each and 16 cartridges of 48 mcg each, plus 2 inhalers. The label includes storage instructions, product and dosage information, and manufacturer details from United Therapeutics Corporation. The design highlights the strength options 32 mcg and 48 mcg per cartridge prominently.*

FDA Label Image

Principal Display Panel (16 mcg 32 mcg 48 mcg Titration Kit)

Packaging label for Tyvaso DPI inhalation powder Titration Kit by United Therapeutics Corporation. The label shows strengths of 16 mcg, 32 mcg, and 48 mcg per cartridge. The box design includes images of the inhaler device and graphics with blue and purple accents on a mostly white and blue background. The kit is intended for oral inhalation and includes multiple cartridges at these strengths.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.